Meaning-Centered Coping Skills Training for Cancer Pain
(MCPC Trial)
Trial Summary
What is the purpose of this trial?
This study is a randomized controlled trial of a psychosocial pain management intervention called, Meaning-Centered Pain Coping Skills Training (MCPC). Patients with advanced solid tumor cancer and pain interference (N=210) will be randomized to MCPC or a standard care control condition. Patient-reported outcomes will be assessed at baseline and 8- and 12-week follow-ups. The risk and safety issues in this trial are low and limited to those common to a psychosocial intervention (e.g., loss of confidentiality).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a psychosocial intervention, so it's likely you can continue your medications, but you should confirm with the trial organizers.
What data supports the effectiveness of the treatment Meaning-Centered Pain Coping Skills Training (MCPC) for cancer pain?
Is Meaning-Centered Coping Skills Training for Cancer Pain safe for humans?
The Meaning-Centered Pain Coping Skills Training (MCPC) has been tested in patients with advanced cancer and showed strong feasibility and acceptability, with high satisfaction reported by participants. No specific safety concerns were noted in the studies, suggesting it is generally safe for humans.12456
How is Meaning-Centered Pain Coping Skills Training (MCPC) different from other treatments for cancer pain?
Research Team
Joseph G Winger, PhD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for English-speaking adults over 18 with advanced solid tumor cancer and pain. They must have a performance status that allows daily activity (ECOG ≤2) and have experienced pain recently. It's not for those with significant cognitive issues, untreated serious mental illness, brain cancer, previous similar therapy experience, or in hospice care.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Meaning-Centered Pain Coping Skills Training (MCPC) through four weekly videoconference sessions focusing on cognitive-behavioral skills for managing pain.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 8-week and 12-week follow-ups.
Treatment Details
Interventions
- Meaning-Centered Pain Coping Skills Training (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Mary E. Klotman
Duke University
Chief Executive Officer since 2017
MD from Duke University School of Medicine
Michelle McMurry-Heath
Duke University
Chief Medical Officer since 2020
MD from Duke University School of Medicine
American Cancer Society, Inc.
Collaborator
Dr. Larry Weiss
American Cancer Society, Inc.
Chief Medical Officer since 2016
MD from Duke University Medical Center
Dr. Wayne A. I. Frederick
American Cancer Society, Inc.
Chief Executive Officer
MD from Howard University, MBA from Howard University